Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 188

1.

Whole-pelvis radiotherapy in combination with interstitial brachytherapy: does coverage of the pelvic lymph nodes improve treatment outcome in high-risk prostate cancer?

Bittner N, Merrick GS, Wallner KE, Butler WM, Galbreath R, Adamovich E.

Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1078-84. doi: 10.1016/j.ijrobp.2009.02.069. Epub 2009 Jun 24.

PMID:
19553031
[PubMed - indexed for MEDLINE]
2.

Androgen deprivation therapy does not impact cause-specific or overall survival in high-risk prostate cancer managed with brachytherapy and supplemental external beam.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen ZA, Adamovich E, Lief J.

Int J Radiat Oncol Biol Phys. 2007 May 1;68(1):34-40. Epub 2007 Feb 7.

PMID:
17289288
[PubMed - indexed for MEDLINE]
3.

High-risk prostate cancer with Gleason score 8-10 and PSA level ≤15 ng/mL treated with permanent interstitial brachytherapy.

Fang LC, Merrick GS, Butler WM, Galbreath RW, Murray BC, Reed JL, Adamovich E, Wallner KE.

Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):992-6. doi: 10.1016/j.ijrobp.2010.07.006. Epub 2010 Oct 6.

PMID:
20932674
[PubMed - indexed for MEDLINE]
4.

Impact of supplemental external beam radiotherapy and/or androgen deprivation therapy on biochemical outcome after permanent prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Lief JH, Allen Z, Adamovich E.

Int J Radiat Oncol Biol Phys. 2005 Jan 1;61(1):32-43.

PMID:
15629591
[PubMed - indexed for MEDLINE]
6.

Relationship between percent positive biopsies and biochemical outcome after permanent interstitial brachytherapy for clinically organ-confined carcinoma of the prostate gland.

Merrick GS, Butler WM, Galbreath RW, Lief JH, Adamovich E.

Int J Radiat Oncol Biol Phys. 2002 Mar 1;52(3):664-73.

PMID:
11849788
[PubMed - indexed for MEDLINE]
7.

Lack of benefit of pelvic radiation in prostate cancer patients with a high risk of positive pelvic lymph nodes treated with high-dose radiation.

Vargas CE, Galalae R, Demanes J, Harsolia A, Meldolesi E, Nürnberg N, Schour L, Martinez A.

Int J Radiat Oncol Biol Phys. 2005 Dec 1;63(5):1474-82. Epub 2005 Jun 20.

PMID:
15964706
[PubMed - indexed for MEDLINE]
8.

Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.

Fitch DL, McGrath S, Martinez AA, Vicini FA, Kestin LL.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1430-9. Epub 2006 Jun 12.

PMID:
16765527
[PubMed - indexed for MEDLINE]
9.

Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer.

Merrick GS, Galbreath RW, Butler WM, Waller KE, Allen ZA, Lief J, Adamovich E.

Cancer. 2007 Jul 15;110(2):289-96.

PMID:
17549691
[PubMed - indexed for MEDLINE]
Free Article
10.

Excellent results from high dose rate brachytherapy and external beam for prostate cancer are not improved by androgen deprivation.

Demanes DJ, Brandt D, Schour L, Hill DR.

Am J Clin Oncol. 2009 Aug;32(4):342-7. doi: 10.1097/COC.0b013e31818cd277.

PMID:
19398902
[PubMed - indexed for MEDLINE]
11.

Prostate brachytherapy in men > or =75 years of age.

Merrick GS, Wallner KE, Galbreath RW, Butler WM, Brammer SG, Allen ZA, Adamovich E.

Int J Radiat Oncol Biol Phys. 2008 Oct 1;72(2):415-20. doi: 10.1016/j.ijrobp.2008.01.017. Epub 2008 Apr 18.

PMID:
18374514
[PubMed - indexed for MEDLINE]
12.

Obesity is not predictive of overall survival following permanent prostate brachytherapy.

Merrick GS, Galbreath RW, Butler WM, Wallner KE, Allen ZA, Adamovich E.

Am J Clin Oncol. 2007 Dec;30(6):588-96.

PMID:
18091052
[PubMed - indexed for MEDLINE]
13.

Biochemical outcome for hormone-naïve patients with high-risk prostate cancer managed with permanent interstitial brachytherapy and supplemental external-beam radiation.

Merrick GS, Butler WM, Lief JH, Galbreath RW, Adamovich E.

Cancer J. 2002 Jul-Aug;8(4):322-7.

PMID:
12184410
[PubMed - indexed for MEDLINE]
14.

Pretreatment serum testosterone and androgen deprivation: effect on disease recurrence and overall survival in prostate cancer patients treated with brachytherapy.

Taira AV, Merrick GS, Galbreath RW, Butler WM, Wallner KE, Allen ZA, Lief JH, Adamovich E.

Int J Radiat Oncol Biol Phys. 2009 Jul 15;74(4):1143-9. doi: 10.1016/j.ijrobp.2008.09.046. Epub 2008 Dec 29.

PMID:
19117691
[PubMed - indexed for MEDLINE]
15.

Influence of body mass index on biochemical outcome after permanent prostate brachytherapy.

Merrick GS, Butler WM, Wallner KE, Galbreath RW, Allen Z, Lief JH, Adamovich E.

Urology. 2005 Jan;65(1):95-100.

PMID:
15667872
[PubMed - indexed for MEDLINE]
16.

Failure-free survival following brachytherapy alone or external beam irradiation alone for T1-2 prostate tumors in 2222 patients: results from a single practice.

Brachman DG, Thomas T, Hilbe J, Beyer DC.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):111-7.

PMID:
10924979
[PubMed - indexed for MEDLINE]
17.

Prostate brachytherapy: treatment strategies.

Stone NN, Stock RG.

J Urol. 1999 Aug;162(2):421-6.

PMID:
10411050
[PubMed - indexed for MEDLINE]
18.

Greater biopsy core number is associated with improved biochemical control in patients treated with permanent prostate brachytherapy.

Bittner N, Merrick GS, Galbreath RW, Butler WM, Adamovich E, Wallner KE.

Int J Radiat Oncol Biol Phys. 2010 Nov 15;78(4):1104-10. doi: 10.1016/j.ijrobp.2010.02.068. Epub 2010 Sep 23.

PMID:
20864268
[PubMed - indexed for MEDLINE]
19.

Stage T1-2 prostate cancer: a multivariate analysis of factors affecting biochemical and clinical failures after radical prostatectomy.

Kupelian PA, Katcher J, Levin HS, Klein EA.

Int J Radiat Oncol Biol Phys. 1997 Mar 15;37(5):1043-52.

PMID:
9169811
[PubMed - indexed for MEDLINE]
20.

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):343-52.

PMID:
10802358
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk